Semaglutide and Pregnancy: What You Need to Know

Understanding Semaglutide and Its Use

Semaglutide is a medication that belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. It works by mimicking a natural hormone in your body that helps regulate appetite and blood sugar levels. The two most well-known brand names for semaglutide are Ozempic and Wegovy. Ozempic is primarily prescribed to help manage blood sugar levels in individuals with type 2 diabetes, and it's used alongside diet and exercise. Wegovy, on the other hand, is approved for weight management in individuals aged 12 and older who have obesity or are overweight with related medical conditions, also in conjunction with diet and exercise modifications.

Both Ozempic and Wegovy are administered through subcutaneous injections. While both can lead to weight loss, Wegovy is specifically indicated for this purpose, whereas Ozempic is often prescribed 'off-label' for weight loss due to its effectiveness. The popularity of semaglutide for weight loss has surged recently, leading many to inquire about its safety during pregnancy.

Can You Take Semaglutide During Pregnancy?

The short answer is no. Healthcare professionals and regulatory bodies strongly advise against taking semaglutide in any form during pregnancy.

The primary reasons for this recommendation are based on available research, primarily from animal studies, which indicate potential risks to the developing fetus. The Food and Drug Administration (FDA) highlights these concerns. Furthermore, intentional weight loss during pregnancy is generally not advised by medical professionals due to potential health implications for both the expectant mother and the baby.

Potential Risks and Complications of Semaglutide in Pregnancy

The FDA's prescribing information for semaglutide includes a strong warning against its use during pregnancy. While human studies on pregnant individuals are limited, animal studies have provided crucial insights into potential risks:

• Birth Defects: Animal studies have shown that semaglutide can lead to structural abnormalities in fetuses.
• Fetal Growth Issues: Exposure to semaglutide during pregnancy has been linked to impaired fetal growth, resulting in babies being born smaller than expected.
• Pregnancy Loss: Some animal studies, including those involving pregnant rats, rabbits, and monkeys, have indicated an increased risk of miscarriage or fetal death.
• Low Birth Weight: The weight-loss effects of semaglutide can contribute to babies being born with a lower birth weight, which can have its own set of health challenges.
• Reduced Food Intake: In animal studies, pregnant animals treated with semaglutide showed reduced food consumption, which could impact nutrient availability for the fetus.

It's important to note that semaglutide remains in the body for an extended period. The FDA recommends discontinuing semaglutide at least two months before attempting to conceive to allow the medication to clear from the system.

Semaglutide and Breastfeeding

Information regarding the safety of semaglutide during breastfeeding is also limited. However, some animal studies suggest that semaglutide can pass into breast milk. While the levels found in milk were lower than in the mother's blood, caution is still advised. Due to the potential risks and lack of comprehensive human data, it is generally recommended to avoid semaglutide while breastfeeding.

When to Stop Semaglutide if Planning Pregnancy

If you are currently taking semaglutide (Ozempic or Wegovy) and are planning to become pregnant, it is crucial to discuss this with your doctor. As mentioned, the FDA recommends stopping semaglutide at least two months before conception. This allows sufficient time for the medication to be eliminated from your body, minimizing potential risks to a developing fetus.

Alternatives and Safe Weight Management During Pregnancy

For individuals who were using semaglutide for weight management before pregnancy, the focus shifts to safe and healthy weight gain during pregnancy. Intentional weight loss is generally discouraged during this period. Instead, the emphasis should be on:

• Balanced Nutrition: Consuming a diet rich in essential nutrients to support both maternal and fetal health.
• Regular, Moderate Exercise: Engaging in physical activities recommended by your healthcare provider.
• Medical Supervision: Working closely with your doctor or a registered dietitian to ensure appropriate weight gain and overall well-being.

If you have type 2 diabetes and are taking semaglutide, your doctor will work with you to find the safest and most effective diabetes management plan during pregnancy. This might involve switching to medications that are considered safe for use during pregnancy.

When to Consult a Doctor

It is essential to consult your doctor in the following situations:

• If you are taking semaglutide and discover you are pregnant.
• If you are planning to become pregnant and are currently using semaglutide.
• If you have any questions or concerns about the safety of your current medications during pregnancy or while breastfeeding.
• If you are seeking advice on weight management or diabetes control during pregnancy.

Your healthcare provider is the best resource for personalized medical advice and can guide you on the safest course of action for your unique situation.

Conclusion

While semaglutide has shown significant benefits for managing type 2 diabetes and promoting weight loss, its use during pregnancy is not recommended due to potential risks to the fetus. Prioritizing maternal and fetal health means discontinuing semaglutide well before conception and focusing on safe, evidence-based approaches to health and weight management throughout pregnancy. Always consult with your healthcare provider for personalized guidance.